1. Home
  2. RCKT vs SDHY Comparison

RCKT vs SDHY Comparison

Compare RCKT & SDHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.23

Market Cap

401.6M

Sector

Health Care

ML Signal

HOLD

Logo PGIM Short Duration High Yield Opportunities Fund

SDHY

PGIM Short Duration High Yield Opportunities Fund

HOLD

Current Price

$16.10

Market Cap

394.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCKT
SDHY
Founded
1999
2020
Country
United States
United States
Employees
202
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
401.6M
394.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RCKT
SDHY
Price
$3.23
$16.10
Analyst Decision
Buy
Analyst Count
14
0
Target Price
$29.73
N/A
AVG Volume (30 Days)
2.4M
65.3K
Earning Date
05-04-2026
01-01-0001
Dividend Yield
N/A
8.46%
EPS Growth
N/A
N/A
EPS
N/A
1.07
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$64.28
N/A
P/E Ratio
N/A
$15.08
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$15.55
52 Week High
$5.45
$17.18

Technical Indicators

Market Signals
Indicator
RCKT
SDHY
Relative Strength Index (RSI) 61.01 54.45
Support Level $3.32 $15.87
Resistance Level $3.52 $16.25
Average True Range (ATR) 0.18 0.17
MACD 0.08 0.01
Stochastic Oscillator 96.47 57.89

Price Performance

Historical Comparison
RCKT
SDHY

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

About SDHY PGIM Short Duration High Yield Opportunities Fund

PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It mainly invests in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments (including derivatives) with similar economic characteristics.

Share on Social Networks: